Araclon Biotech, S.L

Araclon Biotech S.L. is a biotechnology company founded by Pr. Manuel Sarasa. Araclon Biotech is a company dedicated to the research and development of therapies and diagnostic methods to be applied to degenerative diseases, currently focusing on Alzheimers disease. At present, Araclon is working on four different projects: The first of these focuses on the diagnosis of Alzheimers disease (with a detection kit for beta-amyloid 40 and 42 proteins in blood already patented). The second is centred on Alzheimers therapy (immunotherapy based). The third is an emerging project, which attempts to respond to the challenge of predicting Alzheimers disease in totally asymptomatic individuals. And finally, a project related to the development of a therapy for the Parkinsons disease. Our mission To research and develop immunotherapies and diagnostic methods used in the treatment of degenerative diseases. It is our aim to provide effective solutions for such diseases. Our objectives Within the ...